## Abstract ## Objective To investigate the efficacy and safety of leflunomide beyond 2 years in a multinational, openβlabel extension of 2 phase III doubleβblind studies. ## Methods Patients with rheumatoid arthritis (RA) who received leflunomide (100 mg/day for 3 days, 10 mg/day or 20 mg/day t
The incidence of the L.E. cell phenomenon in patients with rheumatoid arthritis. (A two-year study)
β Scribed by John W. Sigler; Raymond W. Monto; Dwight C. Ensign; George M. Wilson Jr.; John W. Rebuck; John D. Lovett
- Publisher
- John Wiley and Sons
- Year
- 1958
- Tongue
- English
- Weight
- 432 KB
- Volume
- 1
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Objective To estimate total direct medical costs in persons with rheumatoid arthritis (RA) and to characterize predictors of these costs. ## Methods Patients (n = 7,527) participating in a longitudinal study of outcome in RA completed 25,050 semiannual questionnaires from January
## Abstract ## Objective To study the specific effects of rituximab treatment on the synovium in patients with rheumatoid arthritis (RA) early after initiation of treatment. ## Methods Seventeen RA patients underwent an arthroscopic synovial biopsy procedure directly before and 1 month after rec
Objective. To determine how well the American College of Rheumatology (ACR; formerly, the American Rheumatism Association) 1987 classification criteria for rheumatoid arthritis (RA), when used at study inclusion in a cohort of 270 patients with early (<1 year) arthritis, predicted a diagnosis of RA